Lactiga is a venture-backed, NIH-funded biotherapeutics company developing patented biologics to treat and prevent infections with a focus on improving the quality of life in patients with Primary Immunodeficiency Diseases. We are unlocking the full therapeutic value of human milk antibodies to create the next-generation of anti-infectives that can battle even the world’s most dangerous pathogens including SARS-CoV-2.
Lactiga has earned awards, media attention (Globe & Mail, CTV, Toronto Star) and is participating in the On Deck Health (ODH2) cohort.
Company Details
- Employees
- 8
- Founded
- -
- Address
- North Brunswick, New Jersey 08902, Us
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.lactiga.com
- Keywords
- Dallas.
- HQ
- North Brunswick, New Jersey
Lactiga Questions
Lactiga's website is http://www.lactiga.com
Lactiga's LinkedIn profile is https://www.linkedin.com/company/lactiga
Lactiga has
8 employees.
View email and phone details for 8
employees at Lactiga.
Lactiga's industry is
Biotechnology Research
Lactiga's top competitors are
Sevillian Laboratories,
Licentiam, Inc.,
Kenox Pharmaceuticals, Inc,
Skunkworx Bio,
Patentvest,
Girls To Industry,
Cover + Associates,
Hl7 Vulcan,
Rik Mehta For U.s. Senate,
Kayothera.
Lactiga's categories are Biotechnology Research
Lactiga's founding year is 2017
